CD274 and adenocarcinoma: The large patient population of 1581 patients (24% Asian, 76% Non-Asian, 100% adenocarcinoma) tested the chemo-containing regimens; 60% of these patients (n = 955) had a PD-L1 CPS score of ≥5.